Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Lake Street has maintained its Buy rating for Evogene (NASDAQ:EVGN) and raised its price target from $2.00 to $3.00. This new target represents a 368.09% increase from the current share price. Evogene's shares have risen by 1.01% over the last 24 hours.

August 18, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lake Street's maintained Buy rating and increased price target for Evogene could potentially boost investor confidence and drive the stock price up.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. In this case, Lake Street's decision to maintain a Buy rating and raise the price target for Evogene could be interpreted by investors as a strong vote of confidence in the company's prospects, potentially leading to increased demand for the stock and a rise in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100